Abstract
The standard method of diagnosing prostate cancer is TRUS-guided biopsy; although there is general consensus on how this procedure should be conducted to maximize prostate cancer detection rates, concerns remain about false-negative results on the one hand and poor representation of cancer, both in terms of burden of disease and of grade, on the other.
HistoScanningTM (HS) (Advanced Medical Diagnostics, Waterloo, Belgium) is a technology that detects specific changes in the tissue morphology by extracting and quantifying statistical features from backscattered ultrasonography data. The core of HistoScanning consists of a set of ‘tissue characterization algorithms’ that has been developed to distinguish cancerous and noncancerous tissues in solid organs.
Different studies have shown that prostate HistoScanning has the ability to identify and locate prostate cancer and, consequently, may aid in pretreatment and presurgical planning. In men with a lesion identified, it has potential to enable improved targeting, allowing better risk stratification by obtaining more representative cores.
______________________________________________________________________________
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
De Coninck V, Braeckman J, Michielsen D (2013) Prostate HistoScanning: a screening tool for prostate cancer? Int J Urol 20(12):1184–1190
Lucidarme O, Akakpo JP, Laurate B (2006) HistoScanning: a new computer aided diagnostic tool for distinguishing benign from malignant ovarian masses; a multicentric study report. Scientific Assembly and Annual Meeting
Hamann MF, Hamann C, Schenk E, Al-Najar A, Naumann CM, Jünemann KP (2013) Computer-aided (HistoScanning) biopsies versus conventional transrectal ultrasound-guided prostate biopsies: do targeted biopsy schemes improve the cancer detection rate? Urology 81(2):370–375
Javed S, Chadwick E, Edwards AA, Beveridge S, Laing R, Bott S, Eden C, Langley S (2014) Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies. BJU Int 114(4):541–548
Aigner F, Frauscher F (2009) RE: Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU Int 103(1):115; author reply 115–6
Simmons LAM, Autier P, Moore CM, Emberton M (2011) Ultrasound spectral interrogation of histological grade in prostate cancer using prostate HistoScanning. Eur Urol Suppl 10:302; abstract nr. 967
Simmons LA, Autier P, Zat’ura F, Braeckman J, Peltier A, Romic I, Stenzl A, Treurnicht K, Walker T, Nir D, Moore CM, Emberton M (2012) Detection, localisation and characterisation of prostate cancer by prostate HistoScanning. BJU Int 110(1):28–35
Braeckman J, Autier P, Garbar C, Marichal MP, Soviany C, Nir R, Nir D, Michielsen D, Bleiberg H, Egevad L, Emberton M (2008) Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU Int 101(3):293–298
Braeckman J, Autier P, Soviany C, Nir R, Nir D, Michielsen D, Treurnicht K, Jarmulowicz M, Bleiberg H, Govindaraju S, Emberton M (2008) The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers. BJU Int 102(11):1560–1565
Salomon G, Spethmann J, Beckmann A, Autier P, Moore C, Durner L, Sandmann M, Haese A, Schlomm T, Michl U, Heinzer H, Graefen M, Steuber T (2013) Accuracy of HistoScanning for the prediction of a negative surgical margin in patients undergoing radical prostatectomy. BJU Int 111(1):60–66
Nunez-Mora C, Garcia-Mediero JM, Patino P, Orellana C, Garrido A, Rojo A, Rendon D (2013) Utility of Histoscanning prior to prostate biopsy for the diagnosis of prostate adenocarcinoma. Actas Urol Esp 37(6):342–346
Macek P, Barret E, Sanchez-Salas R, Galiano M, Rozet F, Ahallal Y, Gaya JM, Durant M, Mascle L, Giedelman C, Lunelli L, Validire P, Nesvadba M, Cathelineau X (2014) Prostate Histoscanning in clinically localized biopsy proven prostate cancer: an accuracy study. J Endourol 28(3):371–376
Schiffmann J, Tennstedt P, Fischer J, Tian Z, Beyer B, Boehm K, Sun M, Gandaglia G, Michl U, Graefen M, Salomon G (2014) Does HistoScanning™ predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate. World J Urol 28(3):371–376
Schiffmann J, Fischer J, Tennstedt P, Beyer B, Böhm K, Michl U, Graefen M, Salomon G (2014) Comparison of prostate cancer volume measured by HistoScanning™ and final histopathological results. World J Urol 32(4):939–944
Bul M, Zhu X, Valdagni R, Pickles T, Kakehi Y, Rannikko A, Bjartell A, van der Schoot DK, Cornel EB, Conti GN, Boeve ER, Staerman F, Vis-Maters JJ, Vergunst H, Jaspars JJ, Strolin P, van Muilekom E, Schroder FH, Bangma CH, Roobol MJ (2013) Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. Eur Urol 63(4):597–603
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Maccagnano, C., Scattoni, V. (2017). HistoScanning. In: Martino, P., Galosi, A. (eds) Atlas of Ultrasonography in Urology, Andrology, and Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-319-40782-1_51
Download citation
DOI: https://doi.org/10.1007/978-3-319-40782-1_51
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40780-7
Online ISBN: 978-3-319-40782-1
eBook Packages: MedicineMedicine (R0)